Ignyta Prices IPO

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 a share. The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. Ignyta's offering was run by Leerink Partners and Ladenburg Thalman & Co. Ignyta is a precision medicine company targeting treatment for cancer.